Buying a pharmacy LLC: the license does not transfer, and the entity type can change the answer

In North Carolina’s Medicaid program, selling a pharmacy corporation’s stock is not a change of ownership. Adding or removing a member of a pharmacy LLC is. The same economic deal produces a different regulatory answer depending on which entity form the seller chose years earlier, and nobody choosing that form was thinking about a sale.

That is the pattern across pharmacy transactions. The state board license, the DEA registration and the Medicaid enrollment each attach to something different, and each uses its own test for whether ownership changed. This page covers who may own a pharmacy, what a sale of the LLC triggers compared with a sale of its assets, and the three places the answers diverge.

A pharmacy’s state license, DEA registration and Medicaid enrollment each define a change of ownership differently, and a deal has to clear all three.

Who may own a pharmacy

Most states let anyone own a pharmacy. The control point is the license, issued to the owner for a specific location, together with a licensed pharmacist in charge who is responsible for the operation.

North Dakota is the exception on ownership itself. It issues pharmacy permits only to pharmacists, or to an entity in which licensed pharmacists hold a majority of the interests and actively manage the pharmacy (N.D. Cent. Code § 43-15-35(5)). California restricts ownership from the other direction. Its Board of Pharmacy may not license a pharmacy to a person authorized to prescribe, to someone sharing a community or financial interest in the license with a prescriber, or to a corporation in which prescribers own 10% or more of the stock (Cal. Bus. & Prof. Code § 4111).

Federal law adds a referral rule. Outpatient prescription drugs are a designated health service under the federal physician self-referral law, so a physician who owns part of a pharmacy may not refer Medicare patients to it for those drugs unless an exception applies (42 U.S.C. § 1395nn).

The license does not transfer, so the threshold decides everything

A pharmacy license is not transferable. In California the license cannot pass from one owner to another (Cal. Bus. & Prof. Code § 4201(f)), and in Texas a pharmacy license is “non-transferable or assignable” (Tex. Occ. Code § 560.101). An asset buyer always needs a new license. The real question is whether a buyer of the LLC’s membership interests, which leaves the licensed entity in place, also needs one. The states answer with different thresholds and different timing.

California requires notice to the board within 30 days when 10% or more of the beneficial interest moves to a new holder, and a new license application approved before closing when the buyer will hold 50% or more (16 Cal. Code Regs. § 1709). Illinois requires a new license when 50% or more of the ownership transfers, filed at least 90 days before the change, and lets the buyer operate in the meantime only under a written power of attorney that leaves violations “the sole responsibility of the seller” (68 Ill. Adm. Code 1330.780, 1330.400(e)). North Carolina requires a new permit when anyone comes to own more than 50% of the permit holder or of “any entity in the chain of ownership above” it, voids the old permit on the transfer date if the new one has not issued, and forbids operating on the seller’s permit by power of attorney, according to the Board of Pharmacy’s notice quoting its rule.

In North Carolina, a sale of the parent company’s equity can require a new pharmacy permit, and the old one dies on the closing date.

South Dakota’s board counts a 50% change at the entity or parent level “by any method,” including a stock purchase. Pennsylvania requires a new permit within 30 days of a change in “controlling interest” and does not define the percentage (49 Pa. Code § 27.11(d)). Texas requires a new license on a change of ownership and keeps the seller responsible for operations until it issues, but its rules and board pages state no percentage for when an equity sale counts.

The structuring consequence: the closing date of a pharmacy sale is set by the state board’s timeline, ranging from a filing 90 days ahead in Illinois to approval before closing in California, and a buyer who closes first and files later can find itself operating without a license.

The DEA registration follows the entity

DEA registration works on a different principle from the state license. A registration ends automatically when the registrant dies, ceases legal existence, discontinues business or surrenders it, and it cannot be assigned without DEA’s written consent (21 C.F.R. § 1301.52(a), (b)). When a pharmacy business transfers to another person, the registrant must notify the DEA Special Agent in Charge at least 14 days before the transfer, take a complete inventory on the transfer date that serves as both the seller’s final inventory and the buyer’s initial one, and remain responsible for the accuracy of records before that date (§ 1301.52(d), (e)). Schedule II drugs move on DEA Form 222.

Read literally, those rules point opposite ways for the two deal structures. An asset sale moves the business to a new entity, so the seller’s registration does not follow the assets and the transfer procedure applies. A sale of 100% of the LLC’s interests leaves the registrant in existence, so the registration does not terminate and the transfer procedure does not apply on its terms, even though California, Illinois and North Carolina would all require a new state license for the same deal. And the DEA’s own Pharmacist’s Manual says a new registrant may not dispense controlled substances until the pharmacy holds a valid state license, so the state board’s timeline governs the DEA timeline too.

The pharmacist in charge is a single point of failure

Every pharmacy needs a pharmacist in charge, and the license depends on that person. California will not issue or renew a pharmacy license without an approved pharmacist in charge, requires notice within 30 days when one stops serving, and allows an interim replacement for up to 120 days. Pennsylvania’s rule bars operating without a pharmacist manager for more than 15 days unless the board grants an extension (49 Pa. Code § 27.11). A sale that loses the pharmacist in charge at closing, because the selling owner was also the pharmacist, has a licensing problem the purchase agreement has to solve before it happens.

Medicaid: where the entity type changes the answer

Federal Medicaid rules require every provider to disclose its 5% owners and to report them again within 35 days after any change in ownership (42 C.F.R. § 455.104). The states then decide what a change of ownership is for enrollment, and here the entity form matters.

North Carolina’s Medicaid program says that the withdrawal, removal or acquisition of an LLC member is a change of ownership, while a “transfer of corporate stock” is not, and requires notice to the state at least 30 days before the effective date. A business lawyer choosing an LLC for a pharmacy rarely asks how the Medicaid program will treat a future sale. In North Carolina, the LLC choice turns an equity sale into a Medicaid change of ownership that a corporation would have avoided.

In North Carolina Medicaid, selling an LLC member’s interest is a change of ownership and selling corporate stock is not.

California shows the other trap, successor liability. A buyer must file a complete Medi-Cal application within 35 days if the Board of Pharmacy requires a new permit, if ownership changes by 50% or more cumulatively, or if the business gets a new taxpayer identification number. The provider number does not transfer. The only way to keep billing under the seller’s number is to sign a successor liability agreement within five days of the transaction, which makes the buyer jointly and severally liable with the seller for the location’s Medi-Cal history (22 Cal. Code Regs. §§ 51000.30, 51000.32). An asset deal designed to leave the seller’s liabilities behind brings the Medi-Cal liability straight back.

A worked example: equity or assets in California

A buyer pays $2,000,000 for a single-location California pharmacy held by Corner Rx LLC.

If the buyer purchases 100% of the membership interests, the transfer of 50% or more of the beneficial interest still requires a new license application approved before closing. The DEA registration stays with the LLC. The Medi-Cal enrollment requires a new application within 35 days because the board issues a new permit. And the buyer inherits everything the LLC carries: past pharmacy benefit manager audit recoupments, Medi-Cal overpayments and controlled-substance recordkeeping exposure.

If a new buyer entity purchases the assets, it needs its own license and may not operate until it issues, its own DEA registration with the seller’s 14-day notice and closing-date inventory, and its own Medi-Cal enrollment. It leaves the seller’s liabilities behind, unless it signs the successor liability agreement to keep billing without a gap, which brings the Medi-Cal liability back.

Buying the LLC does not avoid relicensing in California. It avoids the DEA transfer mechanics and may keep payer contracts in place, at the price of the seller’s audit history. Buying assets buys a clean entity that the buyer often makes unclean again to keep the revenue flowing.

The bottom line

A pharmacy license is issued to an owner for a location and does not transfer, so every asset sale needs a new license.

Most states also require a new license when a buyer acquires 50% or more of the LLC, and North Carolina reaches up the ownership chain to the parent.

The DEA registration follows the entity, so an equity sale and an asset sale trigger different DEA procedures, while the state license controls when the buyer may dispense.

North Dakota requires pharmacist majority ownership, and California bars prescribers and corporations 10% owned by prescribers from holding a pharmacy license.

In North Carolina Medicaid, an LLC membership change is a change of ownership and a corporate stock sale is not.

In California, keeping the seller’s Medi-Cal number requires the buyer to accept joint liability for the seller’s Medi-Cal history.

What this page does not cover

The four ownership models across licensed professions, and the general Medicare and Medicaid ownership rules, are on who is allowed to own a licensed business. Pharmacy as a business, apart from licensing, is in the pharmacy playbook. Pharmacy benefit manager contracts are governed by their own change-of-control clauses, which this page does not survey.

Last verified October 2026.